Compile Data Set for Download or QSAR
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 7081
TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173248(US9096595, 51)
Affinity DataIC50: 0.600nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173207(US9096595, 10)
Affinity DataIC50: 0.700nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173244(US9096595, 47)
Affinity DataIC50: 0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173229(US9096595, 32)
Affinity DataIC50: 0.800nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173246(US9096595, 49)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173247(US9096595, 50)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173217(US9096595, 20)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173242(US9096595, 45)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173238(US9096595, 41)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173206(US9096595, 9)
Affinity DataIC50: 1nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173230(US9096595, 33)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173245(US9096595, 48)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173240(US9096595, 43)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173235(US9096595, 38)
Affinity DataIC50: 2nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173243(US9096595, 46)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173241(US9096595, 44)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173236(US9096595, 39)
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173214(US9096595, 17)
Affinity DataIC50: 4nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173228(US9096595, 31)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173237(US9096595, 40)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173221(US9096595, 24)
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173215(US9096595, 18)
Affinity DataIC50: 6nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173218(US9096595, 21)
Affinity DataIC50: 7nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173200(US9096595, 3)
Affinity DataIC50: 8nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173225(US9096595, 28)
Affinity DataIC50: 8nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173231(US9096595, 34)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173199(US9096595, 2)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173201(US9096595, 4)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173219(US9096595, 22)
Affinity DataIC50: 9nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173227(US9096595, 30)
Affinity DataIC50: 10nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173232(US9096595, 35)
Affinity DataIC50: 11nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173205(US9096595, 8)
Affinity DataIC50: 12nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173223(US9096595, 26)
Affinity DataIC50: 16nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173202(US9096595, 5)
Affinity DataIC50: 16nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173204(US9096595, 7)
Affinity DataIC50: 17nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173198(US9096595, 1)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173213(US9096595, 16)
Affinity DataIC50: 21nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173234(US9096595, 37)
Affinity DataIC50: 27nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173211(US9096595, 14)
Affinity DataIC50: 42nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173216(US9096595, 19)
Affinity DataIC50: 51nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173233(US9096595, 36)
Affinity DataIC50: 65nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173239(US9096595, 42)
Affinity DataIC50: 71nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173203(US9096595, 6)
Affinity DataIC50: 92nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173212(US9096595, 15)
Affinity DataIC50: 136nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173222(US9096595, 25)
Affinity DataIC50: 141nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173209(US9096595, 12)
Affinity DataIC50: 231nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173220(US9096595, 23)
Affinity DataIC50: 354nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173210(US9096595, 13)
Affinity DataIC50: 417nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173208(US9096595, 11)
Affinity DataIC50: 420nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

TargetProstaglandin D2 receptor 2(Human)
Actelion Pharmaceuticals

US Patent
LigandPNGBDBM173224(US9096595, 27)
Affinity DataIC50: 812nMpH: 7.0 T: 2°CAssay Description:Binding assay was performed in a final assay volume of 250 ul. First, 25 ul of test compound, previously diluted in Binding-Buffer (Binding-Buffer: 5...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2016
Entry Details
US Patent

Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: